[Acute hepatitis caused by intravenous amiodarone].
Amiodarone is an antiarrhythmic agent very often used in clinical practice in spite of its large array of adverse effects. We report one patient case with acute hepatitis following intravenous amiodarone treatment and its possible etiology. Our conclusion is the importance of a strict control of parameters in the hepatic functions in patients who require amiodarone therapy.
Paniagua Clusells
J
J
Servicio de Cardiología, Hospital de Barcelona SCIAS.
Arcusa Gavalda
R
R
Goma Masip
F
F
Pons Masanes
S
S
Soler Masana
J M
JM
D000368:Aged; D000369:Aged, 80 and over; D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology*; D004796:Clinical Enzyme Tests; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone
Hepatitis aguda por amiodarona intravenosa.